Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges.
Stem cells, irrespective of their origin, have emerged as valuable reagents or tools in human health in the past 2 decades. Initially, a research tool to study fundamental aspects of developmental biology is now the central focus of generating transgenic animals, drug discovery, and regenerative medicine to address degenerative diseases of multiple organ systems. This is because stem cells are pluripotent or multipotent cells that can recapitulate developmental paths to repair damaged tissues. However, it is becoming clear that stem cell therapy alone may not be adequate to reverse tissue and organ damage in degenerative diseases. Existing small-molecule drugs and biologicals may be needed as "molecular adjuvants" or enhancers of stem cells administered in therapy or adult stem cells in the diseased tissues. Hence, a combination of stem cell-based, high-throughput screening and 3D tissue engineering approaches is necessary to advance the next wave of tools in preclinical drug discovery. In this review, the authors have attempted to provide a basic account of various stem cells types, as well as their biology and signaling, in the context of research in regenerative medicine. An attempt is made to link stem cells as reagents, pharmacology, and tissue engineering as converging fields of research for the next decade.
Nirmalanandhan
Victor Sanjit
VS
University of Kansas Medical Center & Kansas Masonic Cancer Research Center, Department of Pharmacology Toxicology and Therapeutics, The Institute for Advancing Medical Innovation, Kansas City, Kansas 66160, USA.
Sittampalam
G Sitta
GS
D000818:Animals; D055808:Drug Discovery; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology; D014411:Neoplastic Stem Cells / Q000473:pathology; D044968:Regenerative Medicine / Q000639:trends*; D013234:Stem Cells / Q000166:cytology*; D023822:Tissue Engineering / Q000639:trends*